Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Проблема зуда волосистой части головы
Проблема зуда волосистой части головы
Каткова К.В., Плиева К.Т., Денисова Е.В., Жукова О.В., Корсунская И.М. Проблема зуда волосистой части головы. Consilium Medicum. 2022;24(8):516–519. DOI: 10.26442/20751753.2022.8.201809
© ООО «КОНСИЛИУМ МЕДИКУМ», 2022 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2022 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Зуд волосистой части головы беспокоит многих людей. Причинами зуда могут быть системные, психогенные, неврологические и дерматологические заболевания. Среди последних наиболее часто зудом кожи головы сопровождаются себорейный дерматит и псориаз. Патогенез этих нозологий сильно отличается, но в обоих случаях могут наблюдаться изменения микробиоты кожи, поддерживающие воспалительный процесс, а также присутствует шелушение и ряд других клинических проявлений. Помимо адекватной терапии важную роль играет выбор средства ухода. При заболеваниях волосистой части головы в задачи специалиста входит подбор шампуня и других средств, способных дополнить основную терапию. К таким средствам предъявляется ряд требований: они должны способствовать нормализации микробиоты и pH, снятию воспаления, устранению неприятных симптомов, в том числе и зуда. Одним из таких средств является шампунь LE SANTI, демонстрирующий хорошую клиническую эффективность при ряде дерматологических заболеваний.
Ключевые слова: зуд, кожа головы, псориаз, себорейный дерматит, средства ухода
Keywords: itching, scalp, psoriasis, seborrheic dermatitis, care products
Ключевые слова: зуд, кожа головы, псориаз, себорейный дерматит, средства ухода
________________________________________________
Keywords: itching, scalp, psoriasis, seborrheic dermatitis, care products
Полный текст
Список литературы
1. Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol. 2009;89:339-50.
2. Misery L, Sibaud V, Ambronati M, et al. Sensitive scalp: does this condition exist? An epidemiological study. Contact Dermatitis. 2008;58:234-8.
3. T-J Goon A, Yosipovitch G, Chan YH, Goh CL. Clinical characteristics of generalized idiopathic pruritus in patients from a tertiary referral center in Singapore. Int J Dermatol. 2007;46:1023-6.
4. Ferm I, Sterner M, Wallengren J. Somatic and psychiatric comorbidity in patients with chronic pruritus. Acta Derm Venereol. 2010;90:395-400.
5. Lerebours-Nadal L, Beck-Sague CM, Parker D, et al. Severe, disfiguring, pityriasis rubra pilaris in a woman in the Dominican Republic: histopathologic diagnosis and response to antiretroviral therapy. J Int Assoc Provid AIDS Care. 2016;15:11-4.
6. Pakula AS, Paller AS. Langerhans cell histiocytosis and dermatophytosis. J Am Acad Dermatol. 1993;29:340-3.
7. Moghadam-Kia S, Franks AG. Autoimmune disease and hair loss. Dermatol Clin. 2013;31:75-91.
8. Misery L, Rahhali N, Duhamel A, Taieb C. Epidemiology of dandruff, scalp pruritus and associated symptoms. Acta Derm Venereol. 2013;93:80-1.
9. Tosti A. Dermoscopy of the Hair and Nails. 2 ed. Boca Raton: CRC Press, 2015.
10. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-7.
11. Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221-6.
12. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257-63.
13. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-73.
14. Bilac C, Ermertcan AT, Bilac DB, et al. The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol. 2009;75:551.
15. Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9-13.
16. Carstens E, Akiyama T. Itch: Mechanisms and Treatment. Boca Raton: CRC Press Book, 2014.
17. Kim T-W, Shim W-H, Kim J-M, et al. Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density. Ann Dermatol. 2014;26:727-32.
18. Hrehorów E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67-72.
19. Hillen U, Grabbe S, Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis. 2007;56:87-93.
20. Shi M, Zhang H, Chen X, et al. Clinical features of atopic dermatitis in a hospital-based setting in China. J Eur Acad Dermatol Venereol. 2011;25:1206-12.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Derm Venereol. 1980;92(Suppl.):44-7.
22. Farage MA. Perceptions of sensitive skin: changes in perceived severity and associations with environmental causes. Contact Dermatitis. 2008;59:226-32.
23. Muizzuddin N, Marenus KD, Maes DH. Factors defining sensitive skin and its treatment. Am J Contact Dermat. 1998;9:170-5.
24. Saint-Martory C, Roguedas-Contios AM, Sibaud V, et al. Sensitive skin is not limited to the face. Br J Dermatol. 2008;158:130-3.
25. Misery L, Rahhali N, Ambonati M, et al. Evaluation of sensitive scalp severity and symptomatology by using a new score. J Eur Acad Dermatol Venereol. 2011;25(11):1295-8. DOI:10.1111/j.1468-3083.2010.03968.x
26. Tang SC, Yang JH. Dual Effects of Alpha-Hydroxy Acids on the Skin. Molecules. 2018;23(4):863. DOI:10.3390/molecules23040863
27. Salli K, Lehtinen MJ, Tiihonen K, Ouwehand AC. Xylitol's Health Benefits beyond Dental Health: A Comprehensive Review. Nutrients. 2019;11(8):1813. DOI:10.3390/nu11081813
2. Misery L, Sibaud V, Ambronati M, et al. Sensitive scalp: does this condition exist? An epidemiological study. Contact Dermatitis. 2008;58:234-8.
3. T-J Goon A, Yosipovitch G, Chan YH, Goh CL. Clinical characteristics of generalized idiopathic pruritus in patients from a tertiary referral center in Singapore. Int J Dermatol. 2007;46:1023-6.
4. Ferm I, Sterner M, Wallengren J. Somatic and psychiatric comorbidity in patients with chronic pruritus. Acta Derm Venereol. 2010;90:395-400.
5. Lerebours-Nadal L, Beck-Sague CM, Parker D, et al. Severe, disfiguring, pityriasis rubra pilaris in a woman in the Dominican Republic: histopathologic diagnosis and response to antiretroviral therapy. J Int Assoc Provid AIDS Care. 2016;15:11-4.
6. Pakula AS, Paller AS. Langerhans cell histiocytosis and dermatophytosis. J Am Acad Dermatol. 1993;29:340-3.
7. Moghadam-Kia S, Franks AG. Autoimmune disease and hair loss. Dermatol Clin. 2013;31:75-91.
8. Misery L, Rahhali N, Duhamel A, Taieb C. Epidemiology of dandruff, scalp pruritus and associated symptoms. Acta Derm Venereol. 2013;93:80-1.
9. Tosti A. Dermoscopy of the Hair and Nails. 2 ed. Boca Raton: CRC Press, 2015.
10. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-7.
11. Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221-6.
12. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257-63.
13. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-73.
14. Bilac C, Ermertcan AT, Bilac DB, et al. The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol. 2009;75:551.
15. Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9-13.
16. Carstens E, Akiyama T. Itch: Mechanisms and Treatment. Boca Raton: CRC Press Book, 2014.
17. Kim T-W, Shim W-H, Kim J-M, et al. Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density. Ann Dermatol. 2014;26:727-32.
18. Hrehorów E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67-72.
19. Hillen U, Grabbe S, Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis. 2007;56:87-93.
20. Shi M, Zhang H, Chen X, et al. Clinical features of atopic dermatitis in a hospital-based setting in China. J Eur Acad Dermatol Venereol. 2011;25:1206-12.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Derm Venereol. 1980;92(Suppl.):44-7.
22. Farage MA. Perceptions of sensitive skin: changes in perceived severity and associations with environmental causes. Contact Dermatitis. 2008;59:226-32.
23. Muizzuddin N, Marenus KD, Maes DH. Factors defining sensitive skin and its treatment. Am J Contact Dermat. 1998;9:170-5.
24. Saint-Martory C, Roguedas-Contios AM, Sibaud V, et al. Sensitive skin is not limited to the face. Br J Dermatol. 2008;158:130-3.
25. Misery L, Rahhali N, Ambonati M, et al. Evaluation of sensitive scalp severity and symptomatology by using a new score. J Eur Acad Dermatol Venereol. 2011;25(11):1295-8. DOI:10.1111/j.1468-3083.2010.03968.x
26. Tang SC, Yang JH. Dual Effects of Alpha-Hydroxy Acids on the Skin. Molecules. 2018;23(4):863. DOI:10.3390/molecules23040863
27. Salli K, Lehtinen MJ, Tiihonen K, Ouwehand AC. Xylitol's Health Benefits beyond Dental Health: A Comprehensive Review. Nutrients. 2019;11(8):1813. DOI:10.3390/nu11081813
2. Misery L, Sibaud V, Ambronati M, et al. Sensitive scalp: does this condition exist? An epidemiological study. Contact Dermatitis. 2008;58:234-8.
3. T-J Goon A, Yosipovitch G, Chan YH, Goh CL. Clinical characteristics of generalized idiopathic pruritus in patients from a tertiary referral center in Singapore. Int J Dermatol. 2007;46:1023-6.
4. Ferm I, Sterner M, Wallengren J. Somatic and psychiatric comorbidity in patients with chronic pruritus. Acta Derm Venereol. 2010;90:395-400.
5. Lerebours-Nadal L, Beck-Sague CM, Parker D, et al. Severe, disfiguring, pityriasis rubra pilaris in a woman in the Dominican Republic: histopathologic diagnosis and response to antiretroviral therapy. J Int Assoc Provid AIDS Care. 2016;15:11-4.
6. Pakula AS, Paller AS. Langerhans cell histiocytosis and dermatophytosis. J Am Acad Dermatol. 1993;29:340-3.
7. Moghadam-Kia S, Franks AG. Autoimmune disease and hair loss. Dermatol Clin. 2013;31:75-91.
8. Misery L, Rahhali N, Duhamel A, Taieb C. Epidemiology of dandruff, scalp pruritus and associated symptoms. Acta Derm Venereol. 2013;93:80-1.
9. Tosti A. Dermoscopy of the Hair and Nails. 2 ed. Boca Raton: CRC Press, 2015.
10. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-7.
11. Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221-6.
12. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257-63.
13. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-73.
14. Bilac C, Ermertcan AT, Bilac DB, et al. The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol. 2009;75:551.
15. Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9-13.
16. Carstens E, Akiyama T. Itch: Mechanisms and Treatment. Boca Raton: CRC Press Book, 2014.
17. Kim T-W, Shim W-H, Kim J-M, et al. Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density. Ann Dermatol. 2014;26:727-32.
18. Hrehorów E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67-72.
19. Hillen U, Grabbe S, Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis. 2007;56:87-93.
20. Shi M, Zhang H, Chen X, et al. Clinical features of atopic dermatitis in a hospital-based setting in China. J Eur Acad Dermatol Venereol. 2011;25:1206-12.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Derm Venereol. 1980;92(Suppl.):44-7.
22. Farage MA. Perceptions of sensitive skin: changes in perceived severity and associations with environmental causes. Contact Dermatitis. 2008;59:226-32.
23. Muizzuddin N, Marenus KD, Maes DH. Factors defining sensitive skin and its treatment. Am J Contact Dermat. 1998;9:170-5.
24. Saint-Martory C, Roguedas-Contios AM, Sibaud V, et al. Sensitive skin is not limited to the face. Br J Dermatol. 2008;158:130-3.
25. Misery L, Rahhali N, Ambonati M, et al. Evaluation of sensitive scalp severity and symptomatology by using a new score. J Eur Acad Dermatol Venereol. 2011;25(11):1295-8. DOI:10.1111/j.1468-3083.2010.03968.x
26. Tang SC, Yang JH. Dual Effects of Alpha-Hydroxy Acids on the Skin. Molecules. 2018;23(4):863. DOI:10.3390/molecules23040863
27. Salli K, Lehtinen MJ, Tiihonen K, Ouwehand AC. Xylitol's Health Benefits beyond Dental Health: A Comprehensive Review. Nutrients. 2019;11(8):1813. DOI:10.3390/nu11081813
________________________________________________
2. Misery L, Sibaud V, Ambronati M, et al. Sensitive scalp: does this condition exist? An epidemiological study. Contact Dermatitis. 2008;58:234-8.
3. T-J Goon A, Yosipovitch G, Chan YH, Goh CL. Clinical characteristics of generalized idiopathic pruritus in patients from a tertiary referral center in Singapore. Int J Dermatol. 2007;46:1023-6.
4. Ferm I, Sterner M, Wallengren J. Somatic and psychiatric comorbidity in patients with chronic pruritus. Acta Derm Venereol. 2010;90:395-400.
5. Lerebours-Nadal L, Beck-Sague CM, Parker D, et al. Severe, disfiguring, pityriasis rubra pilaris in a woman in the Dominican Republic: histopathologic diagnosis and response to antiretroviral therapy. J Int Assoc Provid AIDS Care. 2016;15:11-4.
6. Pakula AS, Paller AS. Langerhans cell histiocytosis and dermatophytosis. J Am Acad Dermatol. 1993;29:340-3.
7. Moghadam-Kia S, Franks AG. Autoimmune disease and hair loss. Dermatol Clin. 2013;31:75-91.
8. Misery L, Rahhali N, Duhamel A, Taieb C. Epidemiology of dandruff, scalp pruritus and associated symptoms. Acta Derm Venereol. 2013;93:80-1.
9. Tosti A. Dermoscopy of the Hair and Nails. 2 ed. Boca Raton: CRC Press, 2015.
10. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-7.
11. Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221-6.
12. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257-63.
13. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-73.
14. Bilac C, Ermertcan AT, Bilac DB, et al. The relationship between symptoms and patient characteristics among psoriasis patients. Indian J Dermatol Venereol Leprol. 2009;75:551.
15. Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9-13.
16. Carstens E, Akiyama T. Itch: Mechanisms and Treatment. Boca Raton: CRC Press Book, 2014.
17. Kim T-W, Shim W-H, Kim J-M, et al. Clinical characteristics of pruritus in patients with scalp psoriasis and their relation with intraepidermal nerve fiber density. Ann Dermatol. 2014;26:727-32.
18. Hrehorów E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67-72.
19. Hillen U, Grabbe S, Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis. 2007;56:87-93.
20. Shi M, Zhang H, Chen X, et al. Clinical features of atopic dermatitis in a hospital-based setting in China. J Eur Acad Dermatol Venereol. 2011;25:1206-12.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Derm Venereol. 1980;92(Suppl.):44-7.
22. Farage MA. Perceptions of sensitive skin: changes in perceived severity and associations with environmental causes. Contact Dermatitis. 2008;59:226-32.
23. Muizzuddin N, Marenus KD, Maes DH. Factors defining sensitive skin and its treatment. Am J Contact Dermat. 1998;9:170-5.
24. Saint-Martory C, Roguedas-Contios AM, Sibaud V, et al. Sensitive skin is not limited to the face. Br J Dermatol. 2008;158:130-3.
25. Misery L, Rahhali N, Ambonati M, et al. Evaluation of sensitive scalp severity and symptomatology by using a new score. J Eur Acad Dermatol Venereol. 2011;25(11):1295-8. DOI:10.1111/j.1468-3083.2010.03968.x
26. Tang SC, Yang JH. Dual Effects of Alpha-Hydroxy Acids on the Skin. Molecules. 2018;23(4):863. DOI:10.3390/molecules23040863
27. Salli K, Lehtinen MJ, Tiihonen K, Ouwehand AC. Xylitol's Health Benefits beyond Dental Health: A Comprehensive Review. Nutrients. 2019;11(8):1813. DOI:10.3390/nu11081813
Авторы
К.В. Каткова1, К.Т. Плиева1, Е.В. Денисова1,2, О.В. Жукова1,3, И.М. Корсунская*1,2
1 ГБУЗ «Московский научно-практический центр дерматовенерологии и косметологии» Департамента здравоохранения г. Москвы, Москва, Россия;
2 ФГБУН «Центр теоретических проблем физико-химической фармакологии» РАН, Москва, Россия;
3 ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия
*marykor@bk.ru
1 Moscow Scientific and Practical Сenter of Dermatovenereology and Cosmetology, Moscow, Russia;
2 Center for Theoretical Problems of Physico-Chemical Pharmacology, Moscow, Russia;
3 People’s Friendship University of Russia (RUDN University), Moscow, Russia
*marykor@bk.ru
1 ГБУЗ «Московский научно-практический центр дерматовенерологии и косметологии» Департамента здравоохранения г. Москвы, Москва, Россия;
2 ФГБУН «Центр теоретических проблем физико-химической фармакологии» РАН, Москва, Россия;
3 ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия
*marykor@bk.ru
________________________________________________
1 Moscow Scientific and Practical Сenter of Dermatovenereology and Cosmetology, Moscow, Russia;
2 Center for Theoretical Problems of Physico-Chemical Pharmacology, Moscow, Russia;
3 People’s Friendship University of Russia (RUDN University), Moscow, Russia
*marykor@bk.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.